YERVOY

Product NDC
0003-2328
11-digit product format
000032328
Labeler code
0003
Product ID
0003-2328_ecc3bf01-2632-4c2e-85aa-e34da43d25f2
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
ipilimumab
Dosage form
INJECTION
Route
INTRAVENOUS
Labeler
E.R. Squibb & Sons, L.L.C.
Application
BLA125377
Marketing category
BLA
Marketing start
2011-03-25
Substance
IPILIMUMAB
Active strength
5 mg/mL
Pharmacologic classes
CTLA-4-directed Antibody Interactions [MoA], CTLA-4-directed Blocking Antibody [EPC], Increased T Lymphocyte Activation [PE]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
YERVOY
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
IPILIMUMAB5 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
6T8C155666Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 4 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1657005Internal RxNorm lookup
1657007Internal RxNorm lookup
1657012Internal RxNorm lookup
1657013Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
2265ef30-253e-11df-8a39-0800200c9a66Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
362d7abb-94e6-4c60-9a58-266894157713Product name120231023
6bd95106-a412-1dad-b9cc-4cb74bfb27ceProduct name220230315
f1e0dc7e-7d61-4625-b6d9-4894927679d7Product name220211025
a62a50ac-1535-4461-9768-8ae703e2e9fbProduct name120210525
e4870509-7e28-6f92-f0be-dd3dd889a9cfProduct name520200810
6e9d4a47-c464-b93e-aebc-ad7bffc9c4cdProduct name220190619
444b3e50-f226-46ef-bfca-2e7035d140cdProduct name120190611
816b97af-edc5-4060-aff1-b814bdbcad50Product name120190415
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
419aab54-5d5a-4146-9453-026d4a9991beProduct name220170525
fb37bb55-a52d-4c78-a5e8-109754b36b2dProduct name120151105
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831
290f523a-f9db-9774-b5a9-e1f908ac1782Product name120150828
89dac932-b90a-4410-9ab1-84c53e57de25Product name120150316
5668b646-cd56-c3c7-bdea-3f6b1a8840dbProduct name120140508
684ea482-2e8b-14af-5664-b98f1e402036Product name120140508
810ab97e-f109-f41c-7c83-6a652a9cbf43Product name120140508
87711080-88eb-65c5-b2dd-bf99e700a372Product name120140508
8dbefedf-0a0d-a224-5a3c-66dc9e11c2ddProduct name120140508
9514609b-a2a9-f8ec-6ba6-3f8e5ee89877Product name120140508
b060cc1a-fe47-856b-0b77-4448b5963de8Product name120140508
bc07ef78-e82d-0c19-31f4-31f263780582Product name120140508
c6b65c52-69c7-df49-550a-a50c137f6218Product name120140508
ec2149b3-5c6d-5344-f757-c86411073075Product name120140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0003-2328-22YERVOY1 in 1 CARTONINJECTION145
0003-2328-22YERVOY40 mL in 1 VIAL, SINGLE-USEINJECTION4045

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0003-2328-22ML - Milliliter0003-23288489de02-ab49-4adf-b6ca-1b508ac1e7e312012-07-24

DailyMed Socrata Ingredients#

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0003-2328YERVOY (IPILIMUMAB) INJECTION [E.R. SQUIBB & SONS, L.L.C.]44Current NDC, Legacy NDC, 2 package rows20250426_2265ef30-253e-11df-8a39-0800200c9a66.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
YERVOYIPILIMUMABE.R. Squibb & Sons, L.L.C.2265ef30-253e-11df-8a39-0800200c9a662026-06-12Warnings, Adverse reactionsExact identifier
application number: BLA125377
ndc (product): 0003-2328

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125377Yervoyipilimumab351(a)Rx2026-07-01

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1657005ipilimumab 200 MG in 40 ML InjectionPSN2265ef30-253e-11df-8a39-0800200c9a6645
1657012ipilimumab 50 MG in 10 ML InjectionPSN2265ef30-253e-11df-8a39-0800200c9a6645
1657007Yervoy 200 MG in 40 ML InjectionPSN2265ef30-253e-11df-8a39-0800200c9a6645
1657013Yervoy 50 MG in 10 ML InjectionPSN2265ef30-253e-11df-8a39-0800200c9a6645
165701310 ML ipilimumab 5 MG/ML Injection [Yervoy]SBD2265ef30-253e-11df-8a39-0800200c9a6645
165700740 ML ipilimumab 5 MG/ML Injection [Yervoy]SBD2265ef30-253e-11df-8a39-0800200c9a6645
165701210 ML ipilimumab 5 MG/ML InjectionSCD2265ef30-253e-11df-8a39-0800200c9a6645
165700540 ML ipilimumab 5 MG/ML InjectionSCD2265ef30-253e-11df-8a39-0800200c9a6645
1657005ipilimumab 200 MG per 40 ML InjectionSY2265ef30-253e-11df-8a39-0800200c9a6645
1657012ipilimumab 50 MG per 10 ML InjectionSY2265ef30-253e-11df-8a39-0800200c9a6645
1657007Yervoy 200 MG per 40 ML InjectionSY2265ef30-253e-11df-8a39-0800200c9a6645
1657013Yervoy 50 MG per 10 ML InjectionSY2265ef30-253e-11df-8a39-0800200c9a6645

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
0003-2328-22000032328221 VIAL, SINGLE-USE in 1 CARTON (0003-2328-22) / 40 mL in 1 VIAL, SINGLE-USE2011-03-250000-00-00NoNoCurrent